Samlyn Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-448,908
Closed -$15.4M 125
2021
Q4
$15.4M Buy
+448,908
New +$15.4M 0.21% 76